News & Media

HD News:

Sept. 5, 2014 Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease

MELBOURNE, Australia, Sept. 5, 2014 /PRNewswire/ -- Prana Biotechnology (PBT.AX) has today announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation to PBT2 for the treatment of Huntington Disease. To read more Click Here.

Press Releases:

August 26, 2014 aNNUAL CELEBRATION OF HOPE GALA SET OCT 17, 2014

The San Diego Chapter of Huntington’s Disease Society of America (HDSA) will hold its 14th annual Celebration of Hope Gala on Friday, October 17, 2014 at the Manchester Grand Hyatt San Diego. The event, presented by Qualcomm and the Viejas Band of Kumeyaay Indians, raises funds for critical research as well as support services for those families dealing with Huntington’s disease (HD). View here to read more.